Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
| Preferred Name | Valganciclovir | |
| Synonyms |
|
|
| Definitions |
A synthetic prodrug of ganciclovir, a nucleoside analogue of 2'-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication. (NCI04) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C2629 |
|
| Accepted_Therapeutic_Use_For |
Cytomegalovirus retinitis
|
|
| ALT_DEFINITION |
An antiviral agent that is being studied as a treatment for AIDS-related cytomegalovirus. It is changed in the body to ganciclovir.
|
|
| CAS_Registry |
175865-60-8
|
|
| CHEBI_ID |
CHEBI:63635
|
|
| code |
C2629
|
|
| Contributing_Source |
CTRP FDA
|
|
| definition |
A synthetic prodrug of ganciclovir, a nucleoside analogue of 2'-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication. (NCI04)
|
|
| Display_Name |
Valganciclovir
|
|
| FDA_UNII_Code |
GCU97FKN3R
|
|
| Has_Salt_Form | ||
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C176424 |
|
| label |
Valganciclovir
|
|
| Legacy Concept Name |
Valganciclovir
|
|
| NCI_Drug_Dictionary_ID |
38289
|
|
| PDQ_Closed_Trial_Search_ID |
38289
|
|
| PDQ_Open_Trial_Search_ID |
38289
|
|
| Preferred_Name |
Valganciclovir
|
|
| prefixIRI |
NCIT:C2629
|
|
| prefLabel |
Valganciclovir
|
|
| Semantic_Type |
Pharmacologic Substance Nucleic Acid, Nucleoside, or Nucleotide
|
|
| UMLS_CUI |
C0909381
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping